通过虚拟查准多个途径,以确定阿尔茨海默病治疗的多个点药物
Pitchayakarn Takomthong1, Pornthip Waiwut2, Chantana Boonyarat3
1Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Journal of computer-aided molecular design
|May 19, 2025
概括
研究人员确定了一种有前途的多目标化合物VS3 (ZINC006067856),用于阿尔茨海默病 (AD). 这种候选药物显示出抑制胆酶,减少粉样β聚合,提供神经保护的潜力,推动了AD治疗研究.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,有效治疗方法有限.
- 目前的治疗方法只能减缓疾病的进展,这凸显了对新型治疗策略的需求.
- 多目标药物对阿尔茨海默氏症等复杂疾病越来越感兴趣,旨在同时解决多种病理途径.
研究的目的:
- 通过虚拟查来识别潜在的阿尔茨海默病多目标治疗剂.
- 评估ZINC数据库中的化合物,以评估它们解决AD关键病理特征的能力.
主要方法:
- 从ZINC数据库中对化合物的虚拟选 (VS).
- 分子对接以分析联体蛋白相互作用.
- 鉴定到的化合物的体外评估,以对抗AD的病理特征和神经保护作用.
主要成果:
- 一种化合物,ZINC006067856 (VS3),被确定为一个非常有前途的多目标剂.
- VS3表现出胆酶抑制,调节了粉样β (Aβ) 聚合,并促进了Aβ的不稳定.
- VS3对过氧化引起的细胞损伤表现出神经保护作用.
结论:
- VS3显示出作为阿尔茨海默病的综合性,多目标治疗剂的巨大潜力.
- 需要进一步的临床前和临床研究来评估VS3的安全性,疗效和治疗潜力.
- 该研究强调了虚拟查在发现复杂神经退行性疾病的新药候选者的价值.
相关概念视频
Alzheimer's Disease: Treatment
136
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
136
Alzheimer's Disease: Overview
396
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
396


